APGE
Price
$52.95
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
52 days until earnings call
BHVN
Price
$40.42
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
47 days until earnings call
Ad is loading...

APGE vs BHVN

Header iconAPGE vs BHVN Comparison
Open Charts APGE vs BHVNBanner chart's image
Apogee Therapeutics
Price$52.95
Change-$0.00 (-0.00%)
Volume$347.42K
CapitalizationN/A
Biohaven
Price$40.42
Change-$0.00 (-0.00%)
Volume$1.09M
CapitalizationN/A
View a ticker or compare two or three
APGE vs BHVN Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
APGE vs. BHVN commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and BHVN is a Sell.

COMPARISON
Comparison
Sep 21, 2024
Stock price -- (APGE: $53.34 vs. BHVN: $39.40)
Brand notoriety: APGE and BHVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 148% vs. BHVN: 140%
Market capitalization -- APGE: $3B vs. BHVN: $3.72B
APGE [@Biotechnology] is valued at $3B. BHVN’s [@Biotechnology] market capitalization is $3.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $585.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileBHVN’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • BHVN’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while BHVN’s TA Score has 6 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 3 bearish.
  • BHVN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +5.37% price change this week, while BHVN (@Biotechnology) price change was +10.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.40%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was -0.90%.

Reported Earning Dates

APGE is expected to report earnings on Nov 11, 2024.

BHVN is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+0.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($3.82B) has a higher market cap than APGE($3B). APGE YTD gains are higher at: 90.909 vs. BHVN (-7.944). APGE has higher annual earnings (EBITDA): -134.74M vs. BHVN (-774.44M). APGE has more cash in the bank: 676M vs. BHVN (437M). APGE has less debt than BHVN: APGE (4.08M) vs BHVN (29.7M). APGE (0) and BHVN (0) have equivalent revenues.
APGEBHVNAPGE / BHVN
Capitalization3B3.82B79%
EBITDA-134.74M-774.44M17%
Gain YTD90.909-7.944-1,144%
P/E RatioN/AN/A-
Revenue00-
Total Cash676M437M155%
Total Debt4.08M29.7M14%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGEBHVN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
75%
Bearish Trend 10 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPSCX21.540.05
+0.23%
Sterling Capital Behav Sm Cp Val Eq Intl
TMSIX37.09-0.02
-0.05%
Thrivent Mid Cap Stock S
CGFAX74.13-0.20
-0.27%
American Funds Growth Fund of Amer 529A
PIIPX12.06-0.04
-0.33%
Principal International Equity Index R4
FAOCX31.98-0.24
-0.74%
Fidelity Advisor Overseas C

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with ACLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+5.33%
ACLX - APGE
39%
Loosely correlated
+3.28%
ALLO - APGE
38%
Loosely correlated
N/A
BHVN - APGE
35%
Loosely correlated
+1.03%
FATE - APGE
35%
Loosely correlated
-3.00%
SYRE - APGE
35%
Loosely correlated
+1.58%
More

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+1.03%
VCYT - BHVN
43%
Loosely correlated
-1.63%
FOLD - BHVN
41%
Loosely correlated
-2.59%
ACLX - BHVN
37%
Loosely correlated
+3.28%
RCKT - BHVN
37%
Loosely correlated
-4.40%
SWTX - BHVN
36%
Loosely correlated
+0.45%
More